Skip to main content Skip to main navigation menu Skip to site footer
Reumatismo - The Italian Journal of Rheumatology

eISSN 2240-2683

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News

Editor-in-Chief: M.A. Cimmino, Genova, Italy

1.0
Impact Factor 2024
1.7
CiteScore 2024
1.0
Impact Factor 2024
1.7
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • PO:14:197 | Safety of biologic and conventional immunosuppressants in an Italian cohort of patients with systemic lupus erythematosus: a longitudinal analysis from the Lupus Italian Registry pharmacoepidemiologic study promoted by the Italian Society of Rheumatology Davide Rozza1, Carlo Alberto Scirè1|2, Paola Conigliaro3, Giacomo Emmi4, Laura Coladonato6, Salvatore Scarpato7, Luca Iaccarino8, Serena Guiducci9, Giulia Pazzola10, Francesca Romana Spinelli11, Micol Frassi12, Ilaria Cavazzana12, Chiara Scirocco13, Valeria Orefice13, Immacolata Prevete13, Alessandra Bortoluzzi14, Marcello Govoni14, Elena Bartoloni15, Luca Moroni16, Giuseppe Alvise Ramirez16, Valentina Canti16, Giorgio Pettiti17, Maria Chiara Ditto18, Enrico Fusaro18, Marta Mosca19, Lorenzo Cavagna20, Fabrizio Conti11, Andrea Doria8, Gian Domenico Sebastiani13, Sperimentatori Gruppo Lire5 | 1Centro Studi della Società Italiana di Reumatologia, Milano; 2Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca, Monza; 3Università di Roma Tor Vergata; 4Dipartimento di Scienze Mediche, Chirurgiche e della Salute, Università di Trieste; 5https://redcap.reumatologia.it/surveys/?s=LWL7WJM4KHDR97CC; 6Dip di Medicina di Precisione e Rigenerativa e area Jonica, Bari; 7Azienda Sanitaria Locale ASL Salerno; 8Università degli Studi di Padova; 9SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; 10Arcispedale Santa Maria Nuova Reggio Emilia; 11Università degli Studi di Roma La Sapienza; 12Spedali Civili di Brescia; 13Azienda Ospedaliera San Camillo Forlanini, Roma; 14Azienda Ospedaliera Universitaria Sant'Anna, Ferrara; 15SC Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia; 16IRCCS Ospedale San Raffaele, Milano; 17Azienda Ospedaliera S. Croce e Carle, Cuneo; 18AOU Citta' della Salute e della Scienza di Torino; 19AOU Santa Chiara, Pisa; 20Università di Pavia, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2158
    84
  • CO:09:6 | Risk of disease flare during pregnancy and postpartum in inflammatory arthritis: association with therapy discontinuation in the prospective P-RHEUM.it study Dina Zucchi1, Chiara Tani1, Francesca Crisafulli2, Alessia Gatti2, Maria Gerosa3, Cecilia Chighizola3, Melissa Padovan4, Salvatore D'Angelo5, Florenzo Iannone6, Maria Sole Chimenti7, Claudia Lomater8, Francesca Serale9, Veronique Ramoni10, Oscar Epis11, Bernd Raffeiner12, Ariela Hoxha13, Andrea Doria14, Leonardo Santo15, Valentina Canti16, Francesca Bellisai17, Giovanna Cuomo18, on behalf of the P-Rheumit Investigators19, Greta Carrara20, Cristina Di Nicola20, Davide Rozza20, Carlo Alberto Scirè20, Maria Chiara Gerardi11, Angela Tincani2, Laura Andreoli2, Marta Mosca1. | 1Rheumatology Unit, University of Pisa and Azienda Ospedaliero Universitaria Pisana; 2Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia; 3Clinical Rheumatology Division, ASST Gaetano Pini-CTO and University of Milano; 4Rheumatology Unit, Azienda Ospedaliero-Universitaria S. Anna and University of Ferrara; 5Rheumatology Department of Lucania - San Carlo Hospital, Potenza; 6Rheumatology Unit, DiMePRE-J, University of Bari; 7Department of Systems Medicine, Rheumatology, Allergology and Clinical Immunology, University of Rome-Tor Vergata, Roma; 8Torino Academic Rheumatology Center, A.O. Mauriziano di Torino, University of Torino; 9Rheumatology Unit, ASL CN1 Cuneo; 10Internal Medicine Department, ASST Lodi - Ospedale Maggiore di Lodi; 11Division of Rheumatology, Multispecialist Medical Department, Grande Ospedale Metropolitano Niguarda, Milano; 12Department of Rheumatology, Central Hospital of Bolzano SABES-ASDAA, Bolzano; 13General Medicine and Thrombosis and Hemorrhagic Unit, Department of Medicine, University of Padova; 14Rheumatology Unit, Department of Medicine, University of Padova; 15Rheumatology Unit, Mons. Dimiccoli Hospital, Barletta; 16Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano; 17Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena; 18Precision Medicine Department, University of Campania L. Vanvitelli, Napoli; 19The Italian Society for Rheumatology; 20Epidemiology Research Unit of the Italian Society for Rheumatology, Milano, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.1989
    80
  • Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review

    F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo
    08-05-2023
    https://doi.org/10.4081/reumatismo.2023.1571
    2270
    PDF: 1520
  • Temporomandibular joint dysfunction in various rheumatic diseases

    F.J. Aceves-Avila, M. Chávez-López, J.R. Chavira-González, C. Ramos-Remus
    126-130
    24-07-2013
    https://doi.org/10.4081/reumatismo.2013.126
    4251
    PDF: 1532
  • Are there any positive effects of TNF-alpha blockers on bone metabolism?

    B. Seriolo, S. Paolino, A. Sulli, M. Cutolo
    199-205
    https://doi.org/10.4081/reumatismo.2006.199
    1329
    PDF: 1210
  • CO:11:2 | Systemic lupus erythematosus with major neuropsychiatric involvement treated with anifrolumab: literature review and a case report Giulia Rizzo1, Fabio Congiu1, Elisabetta Chessa2, Marta Paola Pireddu1, Elena Ragusa1, Alessandra Oliva1, Marianna Salis1, Alberto Cauli1|2, Matteo Piga1|2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari Italy; 2SC Reumatologia, AOU Cagliari Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2120
    102
  • Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

    Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio
    27-01-2025
    https://doi.org/10.4081/reumatismo.2025.1694
    2194
    PDF: 241
  • Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

    A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti
    104-109
    https://doi.org/10.4081/reumatismo.2004.104
    1277
    PDF: 1053
  • The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

    Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino
    23-07-2025
    https://doi.org/10.4081/reumatismo.2025.1830
    1274
    PDF: 61
  • Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study

    K.T. Koh, C.L. Teh, C.K. Cheah, G.R. Ling, M.C. Yong, H.C. Hong, S.C. Gun
    90-96
    09-09-2016
    https://doi.org/10.4081/reumatismo.2016.872
    2637
    PDF: 1454
  • TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

    I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco
    275-282
    https://doi.org/10.4081/reumatismo.2006.275
    1127
    PDF: 981
  • PO:06:079 | Weighing the burden: how body mass index shapes clinical outcomes in rheumatoid arthritis. Insights from a large Italian cohort Marco Capodiferro1, Marco Fornaro1, Gian Luca Erre2, Matteo Piga3, Elena Bartoloni Bocci4, Andreina Manfredi5, Ennio Giulio Favalli6, Maria Sole Chimenti7, Serena Guiducci8, Eleonora Celletti9, Addolorata Corrado10, Alessandro Giollo11, Simone Parisi12, Ivan Giovannini13, Elisa Gremese14, Garifallia Sakellariou15, Ombretta Viapiana16, Fabiola Atzeni17, Francesca Romana Spinelli18, Fabio Cacciapaglia1|19. | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J University of Bari, Bari, Italy; 2Dipartimento di Scienze Mediche, Chirurgiche e Sperimentali, Università degli Studi di Sassari, Sassari, Italy; 3Rheumatology Unit, AOU Cagliari, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; 4Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 5Rheumatology Unit, Azienda Ospedaliera Universitaria Policlinico of Modena, Modena, Italy; 6Dpt of Rheumatology, G. Pini Institute, Milano, Italy; 7Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 8Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Firenze, Italy; 9Rheumatology Unit, SS Annunziata Hospital, Chieti, Italy; 10Rheumatology Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy; 11Rheumatology Unit, Department of Medicine, University of Padova Hospital Trust, Padova, Italy; 12Rheumatology Department, A.O.U. Città della Salute e della Scienza, Torino, Italy; 13Rheumatology Department, Santa Maria della Misericordia Hospital, Udine, Italy; 14Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy; 15Department of Internal Medicine and Therapeutics, University of Pavia, Istituti Clinici Scientifici Maugeri, Pavia, Italy; 16Rheumatology Unit, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy; 17Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy; 18Reumatology Unit, Department of Internal, Anesthesiological, and Cardiovascular Clinical Sciences, Sapienza University, Roma, Italy; 19Miulli General Hospital Acquaviva - Department of Medicine and Surgery, LUM F. De Gennaro University, Casamassima (BA), Acquaviva delle Fonti (BA), Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2014
    78
  • Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review

    Carlo Perricone, Roberto Dal Pozzolo, Giacomo Cafaro, Santina Calvacchi, Lorenza Bruno, Francesco Tromby, Anna Colangelo, Roberto Gerli, Elena Bartoloni
    25-10-2024
    https://doi.org/10.4081/reumatismo.2024.1685
    2204
    PDF: 654
  • The onset site of rheumatoid arthritis: the joints or the lung?

    G. Cafaro, A. Alunno, V. Valentini, M.C. Leone, E. Marcucci, E. Bartoloni, R. Gerli
    167-175
    31-12-2016
    https://doi.org/10.4081/reumatismo.2016.892
    3005
    PDF: 1659
  • Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

    M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso
    29-12-2022
    https://doi.org/10.4081/reumatismo.2022.1511
    2055
    PDF: 918
  • PO:01:008 | Active sacroiliitis at magnetic resonance enterography increases the risk of axial spondyloarthritis in Crohn’s disease patients, while greater age and disease duration are protective factors: a monocentric retrospective cohort study Gabriele Amati1, Gilda Sandri1|2, Giovanni Ciancio2, Benedetta Bongiovanni1|2, Martina Orlandi1|2, Ottavio Secchi1|2, Davide Vaccari3, Annarita Pecchi4, Angela Bertani5, Maddalena Pecchini5, Pietro Torricelli4, Antonio Colecchia5, Dilia Giuggioli1|2. | 1Struttura Complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 2Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia, Modena, Italy; 3Unità Operativa di Radiologia, Ospedale di Pavullo, AUSL di Modena, Modena, Italy; 4Struttura Complessa di Radiologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy; 5Struttura Complessa di Gastroenterologia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2005
    103
  • PO:19:286 | Genetic testing reveals an unexpected case of mevalonate kinase deficiency in a 37-year-old patient with AA renal amyloidosis and good response to colchicine Francesca Crisafulli1, Paolo Airò2, Federica Mescia3, Gianmarco Lugli3, Gianfranco Savoldi4, Claudia Izzi3|5, Federico Alberici3, Marco Cattalini6, Franco Franceschini1, Micol Frassi2. | 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy; 2Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 3U.O Nefrologia, ASST Spedali Civili di Brescia e Università degli Studi di Brescia, Brescia, Italy; 4Medical genetics Laboratory, Laboratory Department ASST Spedali Civili di Brescia, Brescia, Italy; 5Struttura Complessa di Genetica Clinica, ASST Spedali Civili di Brescia, Brescia, Italy; 6Pediatrics Clinic, University of Brescia and ASST Spedali Civili of Brescia, Brescia, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2049
    67
  • PO:16:235 | Anifrolumab in systemic lupus erythematosus: real-life experience of a single-center cohort Filippo Vesentini1, Luca Iaccarino1, Federico Arru2, Greta Hulej1, Anna Giorgia Osele1, Noemi Merra1, Davide Ragno1, Andrea Doria1, Margherita Zen1 | 1UOC Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova; 2UO Medicina, ASL 3 Nuoro, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2162
    68
  • The role of leukemia inhibitory factor in autoimmune disorders: insights into recovery and treatment

    Zahra Rodgarpoor, Ahmad Meshkin, Mohammadamin Ehramianpour, Fateme Zare
    01-04-2025
    https://doi.org/10.4081/reumatismo.2025.1753
    1504
    PDF: 67
  • Carpal tunnel syndrome in HIV-positive patients coinfected with HCV

    A. Mastroianni, F. Allegrini, S. Nardi, D. Donatucci, F. Girelli, C. Guidi
    164-169
    21-12-2017
    https://doi.org/10.4081/reumatismo.2017.1010
    1841
    PDF: 762
  • Thalidomide in treatment of connective diseases and vasculities

    N. Maruotti, F.P. Cantatore, D. Ribatti
    187-190
    https://doi.org/10.4081/reumatismo.2006.187
    1481
    PDF: 1209
  • PO:04:051 | Application of REMS in the assessment of fragility score and bone mineral density in axial spondyloarthritis and psoriatic arthritis with axial involvement Silvia Valentini1, Stefano Gentileschi1, Pamela Bernardini2, Jurgen Sota1, Caterina Baldi1, Sara Torracchi2, Daniela Melchiorre2, Sabrina Aliberti2, Emilio D'Ignazio1, Carla Caffarelli3, Luca Cantarini1, Serena Guiducci2, Bruno Frediani1 | 1UOC Reumatologia, Dipartimento di Scienze mediche, chirurgiche e neuroscienze, Università degli Studi di Siena; 2SOD Reumatologia, Dipartimento di Medicina Sperimentale e clinica, Università degli studi di Firenze, AOU Careggi; 3UOC Medicina Interna e della Complessità, Dipartimento di Scienze Mediche, chirurgiche e neuroscienze, Università degli Studi di Siena, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2129
    67
  • Polymyositis following varicella and mumps infection in adults: report of two cases

    F. Masini, K. Gjeloshi, E. Pinotti, R. Ferrara, C. Romano, G. Cuomo
    19-12-2023
    https://doi.org/10.4081/reumatismo.2023.1562
    1340
    PDF: 435
  • Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)

    M.T. Riccardi, A. Chialà, F. Iannone, V. Grattagliano, M. Covelli, G. Lapadula
    135-139
    https://doi.org/10.4081/reumatismo.2007.135
    1211
    PDF: 795
  • PO:33:195 | Evaluation of prevalence and role of anti-endothelin type a-receptor and anti-angiotensin ii type 1-receptor antibodies in a cohort of systemic sclerosis patients Clara Minerba1, Sara Ferrigno1, Antonella Grimaldi2, Noemi Aprile3, Daniela Costanza2, Laura Quarta2, Maria Rita Ricciardi2, Daniela Stasi3, Paola Conigliaro1, Alberto Bergamini1, Eugenio Quarta2, Maria Sole Chimenti1. | 1U.O.C. Reumatologia, Dipartimento di Medicina dei Sistemi, Università di, Roma, Tor Vergata, Roma, Italy; 2U.O.S.D. Reumatologia, P.O. Vito Fazzi Lecce Italy; 3U.O.C. Patologia clinica e Microbiologia, P.O. Vito Fazzi Lecce Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2084
    70
  • Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis

    B. Ristic, C. Bonetto, M. Rossini, E. Fracassi, A. Carletto, S. Tosato
    11-09-2024
    https://doi.org/10.4081/reumatismo.2024.1779
    2163
    PDF: 477
  • Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

    G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini
    261-267
    https://doi.org/10.4081/reumatismo.2006.261
    1298
    PDF: 758
  • PO:01:007 | Modulation of cellular senescence in psoriatic arthritis: exploring the potential impact of b/tsDMARDs treatment on telomere length, mtDNA copy number, and oxidative damage Eneida Cela1, Giada De Benedittis2, Arianna D'Antonio1, Andrea Latini3, Chiara Morgante2, Cinzia Cicacci3, Paola Conigliaro1, Mauro Fatica1, Giulia Mori1, Giuseppe Novelli2, Paola Borgiani2, Maria Sole Chimenti1. | 1Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy; 2Department of Biomedicine and Prevention, Section of Genetics, University of Rome Tor Vergata, Rome, Italy; 3UniCamillus Saint Camillus International University of Health Sciences, Rome, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2004
    82
  • PO:16:233 | Efficacy of voclosporin on nephritis in patients with variable gain of function of TLR7 affected by lupus: clinical case Veronica Spedicato1, Laura Coladonato1, Marco Fornaro1, Marlea Lavista1, Daniele Sabella1, Marco Capodiferro1, Maria Morrone1, Crescenzio Scioscia1, Giuseppe Lopalco1, Florenzo Iannone1 | 1Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area JonicaJ, University of Bari, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2161
    80
  • Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis

    I. Olivieri, Salvatore D'Angelo, C. Palazzi, P. Leccese, A. Nigro, A. Padula
    1-3
    28-03-2013
    https://doi.org/10.4081/reumatismo.2013.1
    2343
    PDF: 781
  • PO:21:028 | A difficult case of VEXAS syndrome: management of myelodysplastic syndrome associated with systemic inflammation and infectious complications Sandra Lombardi1, Monica Regis1, Stefano De Luca1, Monica Poiani2, Rossella Stella2, Elisa Lucchini2, Francesco Zaja2, Fabio Fiammengo1 | 1SC Medicina Interna, Azienda Sanitaria Universitaria Giuliano Isontina, Gorizia; 2SC Ematologia, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2181
    71
  • Autologous hematopoietic stem-cell transplantation in diffuse cutaneous systemic sclerosis: a single-center experience

    Marko Barešić, Ljiljana Smiljanić Tomičević, Igor Aurer, Mislav Cerovec, Branimir Anić
    28-05-2025
    https://doi.org/10.4081/reumatismo.2025.1822
    2192
    PDF: 67
  • Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy

    M. Rossini, F.P. Cantatore, A. Del Puente, B. Frediani, D. Gatti, S. Giannini, M. Varenna, O. Viapiana, G.D. Sebastiani
    24-06-2024
    https://doi.org/10.4081/reumatismo.2024.1696
    3428
    PDF: 1479
  • Chronic pain: the burden of disease and treatment innovations

    S. Monti, R. Caporali
    35-44
    23-10-2015
    https://doi.org/10.4081/reumatismo.2015.840
    4100
    PDF: 2741
  • IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

    U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco
    62-73
    https://doi.org/10.4081/reumatismo.2004.1s.62
    1368
    PDF: 1969
  • PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience Vittorio Dibenedetto1|2|3, Nicola Farina1|2, Nicola Boffini1|2, Alessandro Tomelleri1|2, Adriana Cariddi1|2, Elena Baldissera1|2, Marco Matucci-Cerinic1|2|3, Lorenzo Dagna1|2|3. | 1Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; 2Inflammation, Fibrosis and Ageing Intitiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; 3Vita-Salute San Raffaele University, Milano, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2021
    62
  • PO:31:163 | Safety and tolerability of home-based prostacyclin analogue therapy in vascular manifestations of the scleroderma spectrum: results of a monocentric study Alice Dionisi1, Lucrezia Verardi2, Annacarla Finucci2, Paola Volpe2, Anna Cinzia Raspa2, Paola Cipriani1, Raffaele Zicolella2 | 1Reumatologia,Dipartimento di Sscienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila; 2UOC Reumatologia, Ospedale Civile di Pescara, Italy

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2204
    82
  • Low body mass index in long standing rheumatoid arthritis: relation to RA disease activity and functional indices

    S.M. Gamal, A.K. Alkemary, M.A. Abdo, A.H.M. El Dakrony
    72-77
    06-07-2018
    https://doi.org/10.4081/reumatismo.2018.999
    1678
    PDF: 775
  • Dupuytren’s disease. State of the art and therapeutic perspectives

    A. Corrado, F.P. Cantatore
    118-128
    https://doi.org/10.4081/reumatismo.2007.118
    1132
    PDF: 2198
  • Treatment of Wegener’s granulomatosis

    V. Riccieri, G. Valesini
    69-76
    https://doi.org/10.4081/reumatismo.2004.69
    1392
    PDF: 5279
  • Evaluation model of the effect of Rofecoxib on the co-prescription of gastroprotective agents observed during the treatment of ostheoarthritis

    P. Russo, A. Capone, G. Baio, M. Di Martino, L. Degli Esposti, S. Buda, E. Degli Esposti, L. Caprino
    331-339
    https://doi.org/10.4081/reumatismo.2002.331
    778
    PDF: 618
  • Phytothermotherapy with fermenting alpine grass in knee osteoarthritis: mid-long term results

    R. Miori, G. Paolazzi, R. Albertazzi, P. Manica, S. Inchiostro, F. Bonella, R. Bortolotti, A.M. Mariani, P. Bortoli
    282-289
    https://doi.org/10.4081/reumatismo.2008.282
    986
    PDF: 850
  • The treatment of recurrent uveitis with TNFα inhibitors

    P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula
    185-189
    https://doi.org/10.4081/reumatismo.2004.185
    1828
    PDF: 2449
  • PO:02:018 | After-SECs: clinical predictors of secukinumab retention in psoriatic arthritis patients with inadequate response to anti-tumor necrosis factor therapy Francesco Cristiano1, Davide Gaspare Patti1, Valentina Boni1, Stefano Di Murro1, Cesare Gavotti1, Roberta Masnata1, Giulia Calabrese2, Gerlando Natalello2, Giusy Peluso2, Augusta Ortolan1|2, Enrico De Lorenzis1|2, Maria Antonietta D'Agostino1|2. | 1Università Cattolica del Sacro Cuore, Roma, Italy; 2Divisione di Reumatologia ed Immunologia clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

    Società Italiana di Reumatologia
    26-11-2025
    https://doi.org/10.4081/reumatismo.2025.2009
    72
  • Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life

    G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio
    71-74
    23-07-2020
    https://doi.org/10.4081/reumatismo.2020.1267
    1739
    PDF: 1215
  • B cell autoimmunity and bone damage in rheumatoid arthritis

    S. Bugatti, L. Bogliolo, C. Montecucco, A. Manzo
    117-125
    16-12-2016
    https://doi.org/10.4081/reumatismo.2016.914
    3500
    PDF: 2075
  • Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

    V. Bruzzese, J. Pepe
    306-308
    https://doi.org/10.4081/reumatismo.2009.306
    1043
    PDF: 842
  • Membranous nephropathy in a patient with Sjögren’s disease

    Kubra Kaynar, Şeymanur Serdar Kılıçaslan, Sevdegül Mungan, Seda Akduman, Vildan Kumcu, Nihan Yazıcı
    20-05-2025
    https://doi.org/10.4081/reumatismo.2025.1794
    2460
    PDF: 191
  • Metabolic syndrome in inflammatory rheumatic diseases

    D. Malesci, G. Valentini, G. La Montagna
    169-176
    https://doi.org/10.4081/reumatismo.2006.169
    1808
    PDF: 3926
  • PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors

    Cristina Garufi, Silvia Mancuso, Fulvia Ceccarelli, Letizia Caruso, Cristiano Alessandri, Manuela Di Franco, Roberta Priori, Valeria Riccieri, Rossana Scrivo, Simona Truglia, Fabrizio Conti, Francesca Romana Spinelli
    05-11-2024
    https://doi.org/10.4081/reumatismo.2024.1725
    2461
    PDF: 326
151 - 200 of 500 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

authors

FOR AUTHORS
  • ARTICLE PROCESSING CHARGE
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
  • Thanks to Reviewers

Categories

    • Abstract Book
    • Oral Communications - Day 1
    • Posters - Day 1
    • Oral Communications - Day 2
    • Posters - Day 2
    • Oral Communications - Day 3

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • Scilit
  • DOAJ
  • Analytics
  • Società Italiana di Reumatologia
Vol. 77 No. 4 (2025)
Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience
Carmela Coccia et al.
4 August 2025
Vol. 77 No. 4 (2025)
Paratenon effusion of the Achilles tendon: a rare finding
Raphael Micheroli et al.
1 September 2025
Vol. 77 No. 4 (2025)
The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus
Fulvia Ceccarelli et al.
23 July 2025
Vol. 77 No. 4 (2025)
The diagnostic utility of miRNA21 in systemic sclerosis
Gehad Gamal Maghraby et al.
25 September 2025

Keywords

Reumatismo - The Italian Journal of Rheumatology

is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 0048-7449
eISSN: 2240-2683

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

Themes by Openjournaltheme.com

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy